Alex Zhavoronkov — AI Voice Profile | Payloop

A

Alex Zhavoronkov

CEO at Insilico Medicine

Posts tracked from 8/28/2024 to 4/29/2026

Posts Analyzed

74

Platforms

2

Total Engagement

0

Positive Sentiment

85%

63 positive of 74

Tools Discussed by Alex Zhavoronkov

Nomic

llm-provider · 1,878 stars

Outlines

framework · 13,618 stars

Orum

ai-sales

Mem

ai-productivity

Share: Twitter LinkedIn

Developer Profile

20

npm packages

104.1M

weekly downloads

Posts by Platform2.3 posts/week

$2.8B Says AI Wins: Why Lilly Backed AI Drug Discovery ...

The article explains why Lilly invested $2.8 billion in AI drug discovery, emphasizing the potential of AI in transforming the industry.

ai drug discoveryinvestment

AI can be used by consumers for basic health questions ...

AI can assist consumers with basic health questions, potentially reducing the need for in-person doctor visits, as stated by Alex Zhavoronkov.

ai healthcareconsumer use

Their CEO, Alex Zhavoronkov, told CNBC that Insilico has ...

CEO Alex Zhavoronkov announced that Insilico has developed at least 28 drugs using generative AI tools.

drug developmentgenerative ai

Alex Zhavoronkov's Post

Alex Zhavoronkov reflects on the transition from academia to industry and the importance of effective communication regarding AI in pharma.

academic transitionai communication

AI can be used by consumers for basic health questions ...

AI can assist consumers with basic health questions, potentially reducing the need for in-person doctor visits, as stated by Alex Zhavoronkov.

ai healthcareconsumer use

Avg engagement: 0Total: 0

Activity Timeline

Top Topics

ai17healthcare12longevity11ai drug discovery8drug discovery8ai healthcare6generative ai5biotech5pharmaceuticals4biotechnology4consumer use3drug development3aging research3ai in drug discovery3aging3ai leadership3innovation3leadership2robotics2ai drug development2

Platform Distribution

Sentiment Overview

positive

85%63

neutral

15%11

negative

0%0

Top Keywords

alex zhavoronkov64ai50insilico medicine33drug discovery14longevity9drug development7generative ai7healthcare7insilico7doctors5lilly4idiopathic pulmonary fibrosis4health questions3pharma3biotechnology3biotech3leadership2robotics2aging2linkedin2superintelligence2ceo2pharmaceutical2accelerated aging2impact2

Recent Posts

news

$2.8B Says AI Wins: Why Lilly Backed AI Drug Discovery ...

ai drug discoveryinvestment

news

AI can be used by consumers for basic health questions ...

ai healthcareconsumer use

web

Team

teamleadership

news

Their CEO, Alex Zhavoronkov, told CNBC that Insilico has ...

drug developmentgenerative ai

news

Alex Zhavoronkov's Post

academic transitionai communication

news

AI can be used by consumers for basic health questions ...

ai healthcareconsumer use

news

Hong Kong-listed Insilico Medicine has reached a deal ...

airobotics

news

AI can be used by consumers for basic health questions ...

ai healthcareconsumer use

web

Alex Zhavoronkov - AI for Good - ITU

aibiotechnology

news

Insilico Medicine's AI Develops Brain Tumor Drug in Six ...

ai in drug discoverymedical research

news

Alex Zhavoronkov, PhD

ai drug discoveryaging research

news

Generative AI & The Future of Medicine - Cure.

generative aibiotech

news

Something super special arrived in the mail today

ai drug discoveryspace exploration

web

Alex Zhavoronkov - AI Drug Developer Reveals All

ai drug discoverypodcast

news

Alex Zhavoronkov's Post

biotechnologycompany news

news

Alex Zhavoronkov's Post

ai drug discoveryaging research

news

AI Evolution: Scaling Therapeutic Programs

aipharmaceuticals

news

Alex Zhavoronkov, Insilico Medicine | AI Drug Development ...

aidrug development

web

AI drug discovery compresses timelines to 6-8 years

aidrug discovery

web

Alex Zhavoronkov

aihealthcare